Ryan Abbate. President, Pacific Communications, a healthcare communications agency that offers strategic and tactical communications solutions. For more information, visit pacific-com.com. Edward Abrahams, Ph.D. President,The Personalized Medicine Coalition, which brings together the academic, industrial, patient, provider, and payer communities committed to personalized medicine from all parts of the healthcare world. For more information, visit personalizedmedicinecoalition.org. Jonathan Andrus. VP, Data and Study Operations, BioClinica, a global provider of clinical trial management services. Mr. Andrus is also chair of the DIA’s eClinical SIAC and on the board of directors with SCDM. For more information, visit bioclinica.com. Robin Arnold. VP, Product and Portfolio Strategy, IMS?Health, which plays a central role in advancing global healthcare, revealing the insights the market intelligence. For more information, visit imshealth.com. Scott Ballenger. Founder, Trial Acceleration Institute, which collaborates with the entire spectrum of clinical trial stakeholders to improve study cycle times. For more information, visit trialacceleration.com. Brett Barber. Director, Clinical Solutions, Kforce Clinical Research, is a provider of clinical trial resourcing solutions For more information, visit kforce.com/clinicalresearch. Gil Bashe. Executive VP, Makovsky + Company, an independent global public relations, investor relations and branding consultancy, focused in financial services, professional services, healthcare, technology, energy, and branding and interactive. For more information, visit makovsky.com. Helge BastiAn. VP, Research Biotech/Global Marketing, Business Development & Strategy, Sigma Life Science, a Sigma-Aldrich business that offers an array of biologically rich products and reagents that researchers use in scientific investigation. For more information, visit sigmaaldrich.com/life-science.html. Jed Beitler. Chairman, CEO Worldwide, Sudler & Hennessey, a global healthcare marketing and communications organization with offices around the world. For more information, visit sudler.com. Jay Bigelow. President and CEO, MicroMass Communications, which offers capabilities in the application of behavioral science to marketing challenges. For more information, visit micromass.com. Wendy Blackburn. Executive VP, Intouch Solutions Inc., a digital marketing agency servicing the pharmaceutical industry. For more information, visit intouchsol.com. Chris Bogan. CEO, Best Practices, a research, consulting, and publishing firm that provides benchmarking focused on the pharmaceutical, biotech, medical device, and healthcare industries. For more information, best-in-class.com. Jay Bolling. President and CEO, Roska Healthcare Advertising, a full-service ad agency that integrates data and insight-driven marketing and advertising solutions. For more information, visit roskahealthcare.com. Jeff Burkel. Chief Operating Officer, MicroMass Communications, which offers capabilities in the application of behavioral science to marketing challenges. For more information, visit micromass.com. Sharon Callahan. CEO, LLNS, a healthcare advertising communications agency and part of the Diversified Agency Services (DAS) division of Omnicom. For more information, visit llns.com. David Chapman. Managing Partner, Ogilvy CommonHealth Worldwide, one of the largest healthcare communications networks. For more information, visit ogilvycommonhealth.com. Becky Chidester. President, Wunderman World Health, an interactive, digital healthcare agency. For more information, visit wunderman.com. John Cline. CEO, unithink, an electronic clinical research organization that helps clients make the most of the move from paper to digital. For more information, visit unithink.com. Kevin Coker. VP, US Oncology Research at US Oncology, a division of McKesson Corp., an integrated oncology company that unites one of the nation’s largest networks of community-based oncologists. For more information, visit usoncology.com and mckesson.com. Scott Cotherman. CEO, CAHG, an integrated marketing communications network model that is comprised of seven business units and provides brand stewardship throughout a brand’s lifecycle. For more information, visit cahg.com. Chris Cresswell. General Manager, Patient Innovations, DrFirst, which operates in the health IT (HIT) industry and is a provider of stand-alone electronic prescribing (e-prescribing) solutions. For more information, visit drfirst.com. David Cunningham. President and CEO, TrialCard, which offers solutions exclusively for the pharmaceutical industry to support direct-to-consumer and professional marketing, patient-assistance programs, and Phase IV clinical trials. For more information, visit trialcard.com. Michael Curry. Partner, The Curry Rockefeller Group, an independent, full-service healthcare communications agency. For more information, visit curryrockefellergroup.com. Stephen Cutler, Ph.D. Senior VP and Chief Operating Officer, Kendle, a global clinical research organization providing the full range of early- to late-stage clinical development services for the world’s biopharmaceutical industry. For more information, visit kendle.com. Yvonne D’Amelio. Chief Financial Officer, Vox Medica, a community-driven marketing company specializing in healthcare. For more information, visit voxmedica.com. Bassil Dahiyat. CEO, Xencor Inc., which engineers biotherapeutics using a proprietary protein design automation technology platform. For more information, visit xencor.com. Jim Datin. Executive VP and Managing Director,Life Sciences Group, Safeguard Scientifics Inc., which provides growth capital for entrepreneurial and innovative life-sciences and technology companies. For more information, visit safeguard.com. Stephen DeCherney, M.D. Senior VP, Pharmaceutical and Life Sciences Operations, MedAssurant, a medical informatics solutions provider. For more information, visit medassurant.com. Jim DeSanti. CEO, PharmaVigilant, which offers solutions to address the complexities of global clinical research. For more information, visit pharmavigilant.com. Phil Deschamps. President and CEO, GSW Worldwide, an inVentiv Health company, a healthcare advertising agency. For more information, visit gsw-w.com. Patrick Durbin. President, BioPharma Services, Thermo Fisher Scientific, a provider of scientific services. For more information, visit thermoscientific.com. Brian G.M. Durie, M.D. Chairman of the International Myeloma Foundation and Medical Director, Aptium Oncology Myeloma Consortium (AMyC) Aptium Oncology, which works with hospitals and physicians to develop centers designed to accommodate the future of cancer care. For more information, visit aptiumoncology.com. David Fishman. President, Snowfish, which provides insights to healthcare, life-sciences, and biotechnology companies. For more information, visit snowfish.net. Patrick Flochel. Life Sciences Leader for EMEIA, Ernst & Young, a global provider of assurance, tax, transaction, and advisory services. For more information, visit ey.com. Chris Garabedian. President and CEO, AVI BioPharma, which is focused on the discovery and development of novel RNA-based therapeutics for rare and infectious diseases, as well as other select disease targets. For more information, visit avibio.com. Joseph Gattuso. Executive VP, Chief Strategic Officer, Ogilvy CommonHealth Worldwide, one of the largest healthcare communications networks. For more information, visit ogilvycommonhealth.com. Matt Giegerich. Chairman and CEO, Ogilvy CommonHealth Worldwide, one of the largest healthcare communications networks. For more information, visit ogilvycommonhealth.com. Rich Gliklich, M.D. President and CEO, Outcome, a provider of patient registries, studies, and technologies for evaluating real-world outcomes. For more information, visit outcome.com. Mark A. Goldberg, M.D. Chief Operating Officer, Parexel International, a global biopharmaceutical services organization that provides the right level of guidance to bring safe and effective treatments to patients sooner. For more information, visit parexel.com. Gene Guselli. Co-Founder, President, and CEO, InfoMedics Inc., a provider of patient feedback solutions for pharmaceutical companies. For more information, visit infomedics.com. Luis Gutierrez. Senior VP, Pharmaceutical and Life-Sciences Operations, MedAssurant, a medical informatics solutions provider. For more information, visit medassurant.com. Michael Harte. Founder and President, The Harte Group, a functional services management organization (FSMO), which leverages the expertise, flexibility, and experience of functional service providers to deliver trial execution solutions. For more information, visit hartegroup.com. Ron Helm. CEO, Pacific Biomarkers Inc. (PBI), a biomarker laboratory services provider in the drug development industry supporting preclinical and Phase I-IV studies. For more information, visit pacbio.com. John Hudak. Founder and President, Criterium, a global, full-service, and technology-driven contract research organization that offers a mix of high-quality, innovative clinical research solutions for the biopharmaceutical, pharmaceutical, medical device, and CRO industries. For more information, visit criteriuminc.com. Kim Huggins. Owner and President, K HR Solutions LLC, a human resources consulting firm that helps transform individuals and corporate groups into effective leaders and results-oriented teams. For more information, visit khrsolutions.com. Max Jackson. CEO, EMEA/Asia Pacific, Sudler & Hennessey, a global healthcare -marketing and communications organization with offices around the world. For more information, visit sudler.com. Joe Jimenez. CEO, Novartis, a global healthcare company whose diverse portfolio spans innovative pharmaceuticals, generics, vaccines and diagnostics, and consumer health products. For more information, visit novartis.com. Stephen Jones, M.D. Medical Director and Co-Chair of the Breast Cancer Committee, US Oncology Research at US Oncology, a division of McKesson Corp., an integrated oncology company that unites one of the nation’s largest networks of community-based oncologists. For more information, visit usoncology.com or mckesson.com. Dan Junius. President and CEO, ImmunoGen Inc., a developer of targeted anticancer therapeutics. For more information, visit immunogen.com. Marcia Kean. CEO, Feinstein Kean Healthcare, a full-service communications and business consulting firm specializing in the healthcare industry. For more information, visit fkhealth.com. Rick Keefer. President and CEO, Publicis Touchpoint Solutions Inc., which provides a comprehensive and integrated array of multichannel outsourced message solutions to the life-sciences industry. For more information, visit publicistouchpointsolutions.com. Michael Kleinrock. Director, Thought Leadership, IMS Health, which plays a central role in advancing global healthcare, revealing the insights market intelligence. For more information, visit imshealth.com. Jim Knipper. Founder and CEO, J. Knipper and Company Inc., a provider of healthcare marketing solutions in direct marketing, sampling, compliance, information technology, and sales force productivity. For more information, visit knipper.com. Dave Lacey. Senior VP, Discovery Research, Amgen, a human therapeutics company in the biotechnology industry. For more information, visit amgen.com. Nicholas Landekic. President, CEO, and Director, PolyMedix, which is developing novel, first-in-class therapies for serious, life-threatening, acute disorders. For more information, visit ipolymedix.com. Rich Levy. Executive VP, Client Solutions, inVentiv Health, which provides customized solutions for every type of healthcare brand, at every stage. For more information, visit inventivhealth.com. Rob Likoff. Co-CEO, Group DCA, a PDI company, offers brand-building digital outreach as part of a multichannel solution. For more information, visit groupdca.com. Nancy Lurker. CEO, PDI Inc., a provider of integrated multichannel promotion outsource services to both established and emerging U.S.-based biopharmaceutical companies. For more information, visit pdi-inc.com. James Macdonell. VP, Patni Americas, a global IT services company that delivers solutions to pharmaceutical, biotechnology, and medical-device clients. For more information, visit patni.com/life-sciences/overview.aspx. Jeanne Male. President and CEO, Emp-Higher Performance, a consultancy that helps build higher employee performance. For more information, visit emphigher.com. JeanMarie Markham. CEO, Clinlogix, a next-generation clinical research organization that supports the clinical development of drugs, biologics, devices, and diagnostics in discovery and Phase I through Phase IV clinical trials. For more information, visit clinlogix.com. Neil Matheson. CEO, Huntsworth Health, a global family of agencies that provides a full continuum of consulting and communications services to the healthcare and well-being industry. For more information, visit huntsworthhealth.com. Lynn Meyer. Managing Partner, IntegReview Ethical Review Board, which is committed to protecting the rights and welfare of human subjects participating in research. For more information, visit integreview.com. Colin Miller, Ph.D. Senior VP, Medical Affairs, BioClinica, a global provider of clinical trial management services. For more information, visit bioclinica.com. Richard Minoff. Managing Partner, 1 Global Partners LLC, a consultancy focused on strategic planning and commercialization, marketing and life-cycle management, and building high-performance organizations. For more information, e-mail Mr. Minoff at [email protected]. Ed Mitzen. Partner, FingerPaint Marketing, a full-service advertising agency. For more information, visit fingerpaintmarketing.com. Simon E. Moroney, Ph.D. CEO, MorphoSys AG, which is building a strong therapeutic antibody pipeline with more than 60 projects in development. For more information, visit morphosys.com. Michael Naimoli. Worldwide Managing Director, Microsoft Life Sciences, which is committed to improving health around the world through software innovation. For more information, visit microsoft.com. Bill Newell. CEO, Sutro Biopharma, a biopharmaceutical company developing novel and biosuperior protein therapeutics with improved pharmaceutical properties. For more information, visit sutrobio.com. Bob Norris. President and CEO, Complete Healthcare Communications, a strategic medical communications agency that specializes in publication planning. For more information, visit chcinc.com. John Nosta. Chief Creative Officer, Ogilvy CommonHealth Medical Education, one of the largest healthcare communications networks. For more information, visit ogilvycommonhealth.com. Terry Nugent. VP, Marketing, Medical Marketing Service Inc., which provides lists that maximize results and minimize costs in the dynamic medical marketing industry. For more information, visit mmslists.com. Cathy Pagano. President, The Institute for Continuing Healthcare Education, a provider of evidence-based, clinically relevant certified continuing education to physicians, nursing professionals, pharmacists, and other allied healthcare professionals. For more information, visit iche.edu. Michael Parisi. Managing Partner, Ogilvy CommonHealth Worldwide, one of the largest healthcare communications networks. For more &s y;information, visit ogilvycommonhealth.com. Michael Parks. Executive VP, Public Relations and Marketing Communications, Vox Medica, a community-driven marketing company specializing in healthcare. For more information, visit voxmedica.com. Julian M. Parreño. Senior Account Director, Datacore Marketing, a KBM Group Company, part of the Wunderman Network, which combines data-driven intelligence with one-to-one marketing innovation. For more information, visit datacoremarketing.com. Vince Parry. Chief Branding Officer, Y Brand, a division of Ignite Health, which works exclusively in the healthcare and wellness field on creating impactful brand identities. For more information, visit ybrand.com. Donald Phillips, Pharm.D. CEO, Vox Medica, a community-driven marketing company specializing in healthcare. For more information, visit voxmedica.com. Frank X. Powers. President, Dudnyk, an independently owned, full-service branding, medical marketing, and advertising agency. For more information, visit dudnyk.com. Jennifer Price. Senior Director, Clinical Solutions, BioClinica, a global provider of clinical trial management services. For more information, visit bioclinica.com. Charlene Prounis. Managing Partner, Flashpoint Medica, a full-service professional healthcare advertising agency within the worldwide Omnicom Diversified Agency Services network. For more information, visit flashpointmedica.com. John Racik. President and CEO, Stonefly Communications Group, an inVentiv Health company, and a patient-focused, insight-driven health, and well-being advertising agency. For more information, visit stoneflycommunications.com. Julia Ralston, R.Ph. President and CEO, MedErgy HealthGroup, a provider of evidence-based communication solutions through the synergistic blend of our strategic, scientific, and creative skills. For more information, visit medergygroup.com. Will Reese. Chief Innovation Officer, Cadient Group, an interactive marketing company offering full marketing agency services emphasizing digital solutions that targets all businesses and industries. For more information, visit cadient.com. Ken Ribotsky. President and CEO, The Core Nation, a family of healthcare marketing and medical communications companies (Core-Create, Brandkarma, and Alpha & Omega) that offers strategic, branding, and creative consulting services. For more information, visit thecorenation.com. Doug Ringler. CEO, Tolerx, a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by normalizing the immune response. For more information, visit tolerx.com. Charles Rockefeller. Partner, The Curry Rockefeller Group, an independent, full-service healthcare communications agency. For more information, visit curryrockefellergroup.com. John Ross. Chief Operating Officer, SDI, a healthcare analytics organization. For more information, visit sdihealth.com. Keith Ruark. VP, Avos Consulting, a part of INC Research, which helps customers address current and future economic concerns and successfully compete in the increasingly challenging global environment. For more information, visit incresearch.com/avosconsulting.aspx. Peter Sandford. Executive VP, NXLevel Solutions, a developer of technology-delivered learning applications and PharmaCertify, e-learning training for the life sciences. For more information, visit nxlevelsolutions.com. Deborah Schnell. President, Sales and Strategic Planning, Healthy Advice Networks, a provider of trusted, relevant, and easy-to-understand health information to consumers and healthcare professionals when and where they need it. For more information, visit healthyadvicenetworks.com. Tim Shannon. Venture Partner, Canaan Partners, a global venture capital firm that invests in people who turn visionary ideas into valuable and significant technology and healthcare companies. For more information, visit canaan.com. Alison Shurell. VP, Life Sciences Product Marketing, IntraLinks, a global provider of software-as-a-service solutions for securely managing content and exchanging critical business information. For more information, visit intralinks.com. Paul Simms. Chairman, eyeforpharma, which provides forums, industry insights, and intelligence. For more information, visit eyeforpharma.com. David Smoller. President, Research Biotech, Sigma Life Science, a Sigma-Aldrich business that offers an array of biologically rich products and reagents that researchers use in scientific investigation. For more information, visit sigmaaldrich.com/life-science.html. Mike Soenen. President and CEO, ClearTrial, a provider of clinical trial operations software to make the planning, forecasting, and tracking of clinical project and financial performance more efficient. For more information, visit cleartrial.com. Nagaraja Srivatsan. Senior VP and Head of Life Science, North America, Cognizant, a global services partner for the life-sciences industry. For more information, visit cognizant.com. Bill Taaffe. President, Corporate Development, Icon, a global provider of outsourced development services that specializes in the planning, management, execution and analysis of Phase IIb – IV clinical trials to the pharmaceutical, biotechnology, and medical-device industries. For more information, visit iconplc.com. Brad Thompson. CEO, Oncolytics Biotech Inc., a biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. For more information, visit oncolyticsbiotech.com. Al Topin. President, Topin & Associates, an independent, full-service, medical marketing communications company. For more information, visit topin.com. Terrence Tormey. CEO and President, Prevention Pharmaceuticals Inc., which actively pursues compelling nutraceutical product opportunities. For more information, visit preventionpharmaceuticals.com. Tim Tyson. CEO, Aptuit, a provider of drug development solutions to pharmaceutical and biotechnology innovators worldwide. For more information, visit aptuit.com. John M. Vann. Executive VP, Global Corporate Development, Chiltern, a full-service, global contract research organization with experience in the management of Phase I-IV clinical trials across a broad range of therapeutic areas and contract staffing solutions. For more information, visit chiltern.com. Josef Von Rickenbach. Chairman and CEO, Parexel International, a global biopharmaceutical services organization that provides the right level of guidance to bring safe and effective treatments to patients sooner. For more information, visit parexel.com. Matt Wallach. Chief Strategy Officer, Veeva Systems, a provider of SaaS-based CRM solutions for the global life-sciences industry. For more information, visit veevasystems.com. Marc Weiner. Managing Partner, Ogilvy CommonHealth Worldwide, one of the largest healthcare communications networks. For more information, visit ogilvycommonhealth.com. Stephen Wray. President and CEO, Cadient Group, an interactive marketing company offering full marketing agency services emphasizing digital solutions that target all businesses and industries. For more information, visit cadient.com. Kristie Zinselmeier. Director of Marketing, BioPharma Solutions, Baxter, a business unit of Baxter that partners with pharmaceutical companies to support their commercialization objectives by providing scientific expertise, sterile manufacturing solutions, parenteral delivery systems, and customized support services needed to meet the unique challenges that parenteral products face. For more information, visit baxterbiopharmasolutions.com. Jeff Zucker. Senior Director and Global Head, Patient Recruitment, Kendle, a global clinical research organization providing the full range of early- to late-stage clinical development services for the world’s biopharmaceutical industry. For more information, visit kendle.com.
